scispace - formally typeset
U

Ulrich Bogdahn

Researcher at University of Regensburg

Publications -  347
Citations -  36060

Ulrich Bogdahn is an academic researcher from University of Regensburg. The author has contributed to research in topics: Neural stem cell & Neurogenesis. The author has an hindex of 67, co-authored 344 publications receiving 32279 citations. Previous affiliations of Ulrich Bogdahn include Hoffmann-La Roche & Volkswagen Foundation.

Papers
More filters
Journal Article

Transcranial duplex ultrasound: experience with contrast enhancing agents.

TL;DR: Three dimensional image reconstruction may represent a novel option in contrast enhanced transcranial duplex imaging including additional information about 3D structure and continuity in patients with central nervous system vascular and parenchymal anatomy.
Journal ArticleDOI

Chronic inflammatory demyelinating polyradiculoneuropathy: superiority of protein A immunoadsorption over plasma exchange treatment.

TL;DR: In this paper, a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) was treated regularly with plasma exchanges (PE) because response to other therapies including i.v. immunoglobulins was not adequate.
Journal ArticleDOI

Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients.

TL;DR: G-CSF treatment is feasible and safe for ALS patients and may exert its beneficial effects through neuroprotective and -regenerative activities, mobilization of hematopoietic stem cells and regulation of pro- and anti-inflammatory cytokines as well as angiogenic factors.
Journal ArticleDOI

A lightning strike to the head causing a visual cortex defect with simple and complex visual hallucinations.

TL;DR: A 23-year-old mountaineer who was hit by a lightning strike to the occiput causing a large central visual field defect and bilateral tympanic membrane ruptures has a psychological reaction consisting of nightmares with reappearance of the complex visual hallucinations and a depressive syndrome.
Journal Article

Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin

TL;DR: Melanoma-inhibiting activity (MIA/CD-RAP) is widely expressed in human and murine primary cell cultures and cell lines, with nevertheless relative high specificity for melanocytic tumors.